ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,809.88
      0.12%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Alto Neuroscience Inc (ANRO)

      7. Alto Neuroscience Inc (ANRO) News

      ANRO

      Alto Neuroscience (ANRO)

      Alto Neuroscience Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ANRO
      DateTimeSourceHeadlineSymbolCompany
      05/29/20248:05AMBusiness WireAlto Neuroscience to Present at the Jefferies Global Healthcare ConferenceNYSE:ANROAlto Neuroscience Inc
      05/21/20248:29AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANROAlto Neuroscience Inc
      05/21/20248:05AMBusiness WireAlto Neuroscience Appoints Michael Hanley as Chief Operating OfficerNYSE:ANROAlto Neuroscience Inc
      05/14/20244:32PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANROAlto Neuroscience Inc
      05/14/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANROAlto Neuroscience Inc
      05/14/20244:03PMBusiness WireAlto Neuroscience Reports First Quarter 2024 Financial Results and Recent Business HighlightsNYSE:ANROAlto Neuroscience Inc
      05/09/20248:05AMBusiness WireAlto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific ConferencesNYSE:ANROAlto Neuroscience Inc
      04/23/20248:05AMBusiness WireAlto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for SchizophreniaNYSE:ANROAlto Neuroscience Inc
      04/03/20248:05AMBusiness WireAlto Neuroscience Announces Initiation of Phase 2 Study of ALTO-203 in Patients with Major Depressive DisorderNYSE:ANROAlto Neuroscience Inc
      03/21/20244:05PMBusiness WireAlto Neuroscience Reports Full Year 2023 Financial Results and Recent Business HighlightsNYSE:ANROAlto Neuroscience Inc
      03/11/20248:05AMBusiness WireAlto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of DirectorsNYSE:ANROAlto Neuroscience Inc
      03/07/20248:00AMBusiness WireAlto Neuroscience to Participate in Upcoming Investor ConferencesNYSE:ANROAlto Neuroscience Inc
      02/27/20248:00AMBusiness WireAlto Neuroscience to Present at the TD Cowen 44th Annual Healthcare ConferenceNYSE:ANROAlto Neuroscience Inc
      02/06/20244:05PMBusiness WireAlto Neuroscience Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNYSE:ANROAlto Neuroscience Inc
       Showing the most relevant articles for your search:NYSE:ANRO